Navigation Links
Rigel Announces Participation in Upcoming Investor and Partnering Conferences
Date:3/13/2008

SOUTH SAN FRANCISCO, Calif., March 13 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the 11th Annual Lehman Brothers Global Healthcare Conference in Miami, Florida on Tuesday, March 18 at 4:45 p.m. EDT.

Mr. Gower is also scheduled to participate in a panel discussion titled "Biotech Models: Should you Just Go to POC or Should you Go All the Way? A Look at Both-Pros/Cons", at the 2008 Pharmaceutical Strategic Outlook Conference hosted by Windhover Information in New York City on March 20 at 10:30 a.m. EDT.

To access the live audio webcast of the investor presentation or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidate
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Rigel Announces Third Quarter 2007 Financial Results
2. Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
3. Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP
4. Rigel Announces Offering of 4,000,000 Shares of Common Stock
5. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...l device software engineering consulting firm Full...ation. A relatively few medical device software en...ISO 13485 certification. Many medical device maker... ISO standards as well. However, it is somewhat ra...lting firm to achieve the rigorous quality standar...
(Date:12/2/2009)...USNewswire/ -- Results of a large-scale clinical t...Radiological Society of North America (RSNA) provi...ual screening ultrasound for women with dense brea... addition, the study confirmed that MRI is highly ..."We found that annual screening with ultrasound in...
(Date:12/2/2009)...swire/ -- LeapFrog Investments has announced a ZAR...ife, the innovative South African insurer serving ...t brings together LeapFrog, the leading microinsur... most innovative insurance businesses. The announc...ife has developed a distinctive and profitable bus...
(Date:12/2/2009)...y comparing standard conservative therapy to a min... decompression for painful herniated disc revealed...hort run, only disc decompression kept patients pa...y, the first of its kind, were presented today at ...North America (RSNA). , Discs are sponge-like cu...
(Date:12/1/2009)...t Medical Center in Oak Lawn, Ill. has become the ...the first for Chicago’s south and southwest ...’s plans today (December 1) by the Illinois ... Springfield, Ill. (Vocus) --.... has become the state’s newest kidney trans...
Breaking Medicine News(10 mins):Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3
...ey inhibit runaway immune system response , ...s taken from the fat tissue of people with multipl...sts a preliminary study that included three patien...he use of SVF cells to treat multiple sclerosis an...
... 26, 2009Tadalafil may improve lower urinary tract... (BPH). Researchers from Nashville, Dallas, San An... during the 104th Annual Scientific Meeting of the...least a six month diagnosis of BPH-LUTS with an In...
...re on abstracts or posters to be presented at the ...9, April 25-30, or the concurrent Engineering & Ur...go, Ill. , GIVING PROSTATE CANCER THE COLD SHOUL...3 B @ McCormick Place West , Johns Hopkins scient...
... immediate action to keep the Obama Administration...S treatment and prevention funding , , WASHINGTON...bal AIDS Coordinator on Monday, has a unique oppor...rough the U.S. foreign assistance budget. , , In ...
...ould allow more potent treatment with fewer side e...ews) -- Nanoparticles designed to provide more dir...eveloped by U.S. researchers. , Made from a safe, ...to carry a higher concentration of anti-cancer dru...
... STIX Market Research , an association of tech...riters, has celebrated its tenth year in business....ociates and tripling of publication schedule by mi...rchers, and science writers, has celebrated its te...
Other Medicine News:Health News:Fat-Derived Stem Cells Might Treat MS 2Health News:American Urological Association/Engineering & Urological Society 2009 -- news tips 2Health News:American Urological Association/Engineering & Urological Society 2009 -- news tips 3Health News:American Urological Association/Engineering & Urological Society 2009 -- news tips 4Health News:American Urological Association/Engineering & Urological Society 2009 -- news tips 5Health News:Global AIDS Alliance Fund Welcomes Eric Goosby to Office of The Global Aids Coordinator 2Health News:Nanoparticles May Help Attack Cancer More Directly 2Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 2Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 4
(Date:12/2/2009)..., ALISO VIEJO, Calif., Dec. 2 /PRNewswire-FirstC... technology and services resource for pathologists...ay announced a Chief Financial Officer transition ...chael R. Rodriguez to become its Senior Vice Presi...09. Raymond J. Land, age 64, the current Senior Vi...
(Date:12/1/2009)... , MONTREAL and DUSSELDORF, Germany, Dec. ...g manufacturer of specialized graphics solutions, ...s now shipping the Matrox Xenia(TM) Series displa...d Mammography solutions using Fujifilm Synapse. ,...omputer based radiography, offering the world,s fi...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlin...t is available in its catalogue: ,, Medical O..., http://www.reportlinker.com/p0164334/Medical-Ox..., Worldwide medical oxygen systems market for h...th coming years. The buoyant growth expectations s...
Breaking Medicine Technology:Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Patient Safety Technologies Reports Third Quarter Results 6358 1Patient Safety Technologies Reports Third Quarter Results 6358 2Patient Safety Technologies Reports Third Quarter Results 6358 3Patient Safety Technologies Reports Third Quarter Results 6358 4Patient Safety Technologies Reports Third Quarter Results 6358 5Patient Safety Technologies Reports Third Quarter Results 6358 6VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 1VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 2Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 1Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 2Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 3Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 4Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 5Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 6Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 7Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 8Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 9Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 10Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 11Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 12Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 13Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6354 14
...SING-WEIHENSTEPHAN and JENA, Germany, July 17 ,Pie...ticalins(R), a novel,class of targeted human prote...ervice contract manufacturer of biopharmaceuticals...he development of Pieris, PRS-050,Anticalin(R) for...s a next generation VEGF antagonist and,as the fir...
...ce-daily TMC278, the third anti-HIV compound to be...ology portfolio -, YARDLEY, Pa., July 17 Tibotec...or phase III efficacy trials examining TMC278,its ...se inhibitor (NNRTI),in treatment-naive adults wit...rials will compare the efficacy, safety and tolera...
Other Medicine Technology:Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050 2Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV 2Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV 3
... magnification for advanced surgical procedures. P...ven at the highest magnification. 3.5x, 4.5x and 5...ion is ideal for surgical applications. Precision ...duce a superior image. The compact abd lightweight...
... high power negative lens delivering magnification...system is ease of use. Movement whilst maintaining...depth of field. The ultra lightweight aluminum bar... stability for the mounted loupes and optimal foca...
SuperVu Galilean System
Anterior Chamber Irrigating Cannula
Medicine Products: